Prevalence and risk factors for efavirenz-based antiretroviral treatment–associated severe vitamin D deficiency: A prospective cohort study

Initiation of efavirenz-based combination antiretroviral therapy (cART) is associated with Vitamin D deficiency, but the risk factors including efavirenz pharmacokinetics for cART-induced severe vitamin D deficiency (SVDD) and the impact of anti-tuberculosis (TB) cotreatment are not explored. We inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Nylén, Hanna, Habtewold, Abiy, Makonnen, Eyasu, Yimer, Getnet, Bertilsson, Leif, Burhenne, Jürgen, Diczfalusy, Ulf, Aklillu, Eleni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400328/
https://www.ncbi.nlm.nih.gov/pubmed/27559961
http://dx.doi.org/10.1097/MD.0000000000004631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400328/
https://www.ncbi.nlm.nih.gov/pubmed/27559961
http://dx.doi.org/10.1097/MD.0000000000004631

Ejemplares similares